Literature DB >> 32715367

Spray-Dried Rosuvastatin Nanoparticles for Promoting Hair Growth.

Amr Maged1, Azza A Mahmoud2,3, Salwa Salah4, Nehad M Abd-Elmonsif5, Mahmoud M Ghorab4.   

Abstract

In this research, we examined the effect of rosuvastatin calcium-loaded nanoparticles on the hair growth-promoting activity on Albino rats. Nanoparticles were prepared using 2:1 weight ratio of drug to methyl-β-cyclodextrin with 10, 20, and 30% stabilizers (phospholipid, polyvinyl pyrrolidone K30, and Compritol 888 ATO) using nanospray dryer. Subsequently, the prepared nanoparticles were evaluated for their process yield, particle size, polydispersity index, zeta potential, and in vitro drug release as well as in vivo studies. The dried nanoparticles showed process yield values up to 84% with particle size values ranging from 218 to 6258 nm, polydispersity index values ranging from 0.32 to 0.99, and zeta potential values ranging from - 6.1 to - 11.9 mV. Combination of methyl-β-cyclodextrin with 10% polyvinyl pyrrolidone K30 accomplished nanoparticles with the lowest particle size (218 nm) and polydispersity index (0.32) values. These nanoparticles had suitable process yield value (70.5%) and were able to retard drug release. The hair growth-promoting activity for the selected nanoparticles revealed the highest hair length values in Albino rats after 14 days of the hair growth study compared with non-medicated nanoparticles, nanoparticles' physical mixture, rosuvastatin solution, and marketed minoxidil preparation groups as well as the control group. The immunohistochemistry images for both selected nanoparticles and marketed minoxidil groups showed a significant increase in the diameter of hair follicle and percent area fraction of cytokeratin 19 in the outer root sheath of hair follicle compared with other tested groups. Rosuvastatin nanoparticles prepared by nanospray drying technique could be a good competitor to minoxidil for hair growth-promoting activity. Graphical abstract.

Entities:  

Keywords:  hair growth promotion; nanoparticles; nanospray dryer; statins

Mesh:

Substances:

Year:  2020        PMID: 32715367     DOI: 10.1208/s12249-020-01746-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  4 in total

1.  PLGA-modified Syloid®-based microparticles for the ocular delivery of terconazole: in-vitro and in-vivo investigations.

Authors:  Nada Zaghloul; Azza A Mahmoud; Nermeen A Elkasabgy; Nada M El Hoffy
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 2.  Merits and advances of microfluidics in the pharmaceutical field: design technologies and future prospects.

Authors:  Amr Maged; Reda Abdelbaset; Azza A Mahmoud; Nermeen A Elkasabgy
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

3.  Design and Characterization of Spray-Dried Proliposomes for the Pulmonary Delivery of Curcumin.

Authors:  Islam M Adel; Mohamed F ElMeligy; Mohamed E A Abdelrahim; Amr Maged; AbdelFattah A Abdelkhalek; Azza M M Abdelmoteleb; Nermeen A Elkasabgy
Journal:  Int J Nanomedicine       Date:  2021-04-07

Review 4.  Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders.

Authors:  Yueting Gu; Qiong Bian; Yanjun Zhou; Qiaoling Huang; Jianqing Gao
Journal:  Asian J Pharm Sci       Date:  2022-05-05       Impact factor: 9.273

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.